GlassScriptPrepare for your visit
Joseph W Kim
Medical Oncology · New Haven, CT · NPI 1295913531
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$24,319.94
in general payments reported to CMS, 2019-2025 · $213 in 2025
The $213 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Who reported paying
General payments only, top 6 by amount.
- Genzyme Corporation $14,494.12
- Janssen Biotech, INC. $1,947.50
- F. Hoffmann-La Roche Ag $1,919.81
- Emd Serono, INC. $1,750.00
- Clovis Oncology, INC. $1,500.00
- Janssen Scientific Affairs, LLC $1,120.03
Drugs and devices associated with these payments
Provenge Cabometyx Xtandi Erleada
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Joseph Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/331552/joseph-w-kim